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ABSTRACT
mirConnX is a user-friendly web interface for infer-
ring, displaying and parsing mRNA and microRNA
(miRNA) gene regulatory networks. mirConnX
combines sequence information with gene expres-
sion data analysis to create a disease-specific,
genome-wide regulatory network. A prior, static
network has been constructed for all human and
mouse genes. It consists of computationally pre-
dicted transcription factor (TF)-gene associations
and miRNA target predictions. The prior network is
supplemented with known interactions from the lit-
erature. Dynamic TF- and miRNA-gene associations
are inferred from user-provided expression data
using an association measure of choice. The static
and dynamic networks are then combined using an
integration function with user-specified weights.
Visualization of the network and subsequent
analysis are provided via a very responsive graphic
user interface. Two organisms are currently
supported: Homo sapiens and Mus musculus. The
intuitive user interface and large database
make mirConnX a useful tool for clinical scientists
for hypothesis generation and explorations.
mirConnX is freely available for academic use at
http://www.benoslab.pitt.edu/mirconnx.
INTRODUCTION
Since its discovery two decades ago, it has become increas-
ingly clear that microRNAs (miRNAs) play a crucial role
in modulating gene expression at the post-transcriptional
level. The small, 22-nt long RNA molecules ﬁne-tune gene
expression by base pairing to target messenger RNAs,
resulting in its degradation or causing translational repres-
sion. As Pandit et al. (1) has shown, deregulation of even a
single miRNA may cause complex human diseases.
Regulatory network reconstruction methods have trad-
itionally involved transcriptional regulation only.
Incorporating miRNAs thus becomes the next natural
step. Only few tools have explored ways to associate
mRNA and miRNA expression to infer regulations.
MMIA (2) and MAGIA (3), for example, utilize associ-
ation metrics such as correlation and mutual information.
In a different context, Huang et al. (4) employed a
Bayesian model to identify miRNA targets from sequence
features and expression data. However, there are several
limitations to these tools. MMIA only examines a subset
of miRNAs that are signiﬁcantly up- or downregulated,
and omits those that could potentially be signiﬁcantly
correlated with their targets if they are not considered to
be differentially expressed, based on the speciﬁc threshold.
This only limits the data to those with a control/disease
contrast, excluding possible use of time-series data.
GenMir+ + (4) is a more sophisticated algorithm, but it
becomes computationally inefﬁcient when a large number
of genes is considered. Furthermore, it does not take into
account other supporting information such as the tran-
scriptional regulation. In fact, none of these tools incorp-
orates the full set of transcription factors (TFs) in the
global network construction. Additionally, network motifs
such as feed-back and feed-forward loops that are known
to have an important role in cancer development and
other diseases are usually not identiﬁed as part of the
routine analyses of the currently available tools.
To this end, we developed mirConnX to attempt to
address some of the above concerns. mirConnX (http://
www.benoslab.pitt.edu/mirconnx) takes advantage of
prior knowledge (from sequence data), and incorporates
evidence from gene expression data to create condition-
speciﬁc genome-wide regulatory networks. mirConnX
also aims to identify gene network motifs, involving tran-
scription factors and miRNAs, that are associated with
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TOOL DESCRIPTION
General framework
mirConnX aims to provide an integrated environment
that allows the user to infer genome-wide transcriptional
(TF-gene/miRNA) and post-transcriptional (miRNA-
gene/TF) regulatory networks for a particular disease or
condition. We consider mRNA and miRNA expression
data measured under the same set of conditions, or at
the same time points, or from the same corresponding
diseased or normal samples (matching samples). The
mRNA and miRNA expression data are pre-processed
to remove genes that are lowly expressed with limited
variance overall. Then, we connect TFs and miRNAs to
genes using a statistical association measure. The associ-
ation network that is constructed reﬂects the disease status
or the condition of interest. This network is an undirected
graph, in which an edge exists between two nodes (genes)
if an interaction has been detected. Note that such associ-
ation networks do not discriminate between direct and
indirect interactions. This network is then superimposed
to a pre-compiled, species-speciﬁc prior network, which is
derived from TF motif scanning and binding, miRNA
target predictions and the literature evidence. The prior
network is a directed, weighted graph, in which an edge
between a TF or miRNA and a gene exists if the former is
predicted to regulate the latter. All connections in the
prior network correspond to direct, predicted or veriﬁed
interactions. Superimposing the two networks via an inte-
gration function results in a directed network, which is
expected to contain signiﬁcantly fewer indirect inter-
actions (depending on the weight the user assigns on the
prior network). mirConnX web tool allows easy visualiza-
tion and exploration of the network, and identiﬁes
network motifs. In the following sections, we describe
the construction of the context-dependent (dynamic) asso-
ciation network, the construction of the prior (static)
network and their integration. Figure 1 presents an
overview of the mirConnX pipeline.
Input formats
mirConnX accepts normalized mRNA and miRNA ex-
pression data in tab-delimited ﬁles, where the ﬁrst row con-
tains sample IDs and the ﬁrst column contains mRNA or
miRNA IDs. mirConnX supports gene symbols, Ensembl
Gene ID, Ensembl Transcript ID, Entrez Gene ID, RefSeq
DNA ID and Unigene ID as mRNA identiﬁers and
miRBase miRNA ID and Accession numbers as miRNA
identiﬁers. An example of the matching mRNA–miRNA
data sets can be found and pre-loaded on the front page.
Note that the sample IDs for mRNA and miRNA data
should match. Any unmatched samples are discarded.
mirConnX allows multiple columns with the same header
in case of biological or technical replicates. The input data
sets are stored only during a user’s session and are used to
construct the association network. If no miRNA data ﬁle is
included, the resulting network will show only TF-gene
interactions. We currently support two organisms: human
(Homo sapiens) and mouse (Mus musculus), as genome an-
notation and prior information is most abundant for these
species.
Constructing the prior network from sequence and
literature data
The prior network is constructed by combining all predic-
tions of TF to gene and TF to miRNA interactions and all
miRNA target predictions. The network is then enhanced
by literature evidence that conﬁrms the existence of an
edge. This results in a directed network that represents
the collection of prior knowledge on regulatory potentials
between genes.
TF to gene/miRNA regulations. We deﬁne the binding po-
tential (RgTF) of a promoter sequence for a given gene/
miRNA as the maximum score between literature evidence
(SLIT 2 {0,1}) and TF binding score (STF), which is
calculated using a sliding window method (5) on the pro-
moters of genes and miRNAs. The JASPAR (6) and
TRANSFAC (7) position weight matrices (PWMs) are
used for the scanning. A subsequence is considered as a
binding site for a TF if its PWM score is on the top 1% of
all scores for this PWM. In addition, UCSC Regulation
Track Conserved TFBS Scores (SCONS) are added to
enhance conﬁdence. The sum of STF and SCONS is
normalized to a score between 0 and 1. Finally, if an ex-
perimentally veriﬁed binding motif for a given TF is avail-
able for this promoter (e.g. in TRANSFAC), then SLIT
becomes 1, and so does RgTF:
RgTF ¼ max ðjSTFj+jSCONSjÞ,SLIT

Regular gene promoters were deﬁned as the region 5kb
upstream of TSS. Promoters are obtained from Database
of Transcription Start Sites (DBTSS) (8), The Eukaryotic
Promoter Database (EPD) (9) and UCSC genome browser
Regulation–Transcription track (Eponine and SwitchGear
TSS). miRNA TSSs are deﬁned using a combination of
predictions and experiments from CoreBoost_HM (10),
Marson et al. (11) and Corcoran et al. (12). Human
(NCBI36/Hg18) and mouse (NCBI37/mm9) sequence
data were downloaded from UCSC genome browser (13).
miRNA to gene/TF regulations. miRNA target prediction
algorithms generally do not agree very well. Thus, we used
a combination of ﬁve target prediction algorithms that
take into account the seed sequence, ﬂanking sequences
and context, binding energy and conservation. These al-
gorithms are: PITA (14), miRANDA (15), TargetScan 5.0
(16), RNAhybrid (17) and Pictar (18). We deﬁne the regu-
latory potential (RgmiR) of an miRNA for a gene as the
proportion of the target prediction algorithms predicting
the gene to contain at least one miRNA target site.
If predictions for corresponding genome versions are
not available, we ran the algorithms using default param-
eters and cutoffs. In addition, if the 30-UTR of a gene
contains an experimentally veriﬁed site from TarBase
(19) or miRecords (20), then STarBase or SmiRecords
Nucleic AcidsResearch, 2011, Vol.39, WebServer issue W417Figure 1. Overview of the integrated analysis in mirConnX. Visualization is achieved with the use of Cytoscape Web v0.7.2 (25). Feed-forward loops
are displayed on a separate tab. Links to external databases provided for every coding gene or miRNA. Statistical analysis on GO pathway (45)
overrepresentation in a user-selected set of genes will be added soon.
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tory potential of the gene for a given miRNA:
RgmiR ¼ max jSpredictionj,STarBase,SmiRecords

Human and mouse 30-UTRs were downloaded from
UCSC genome browser. The list of mature and comple-
ment miRNAs, as well as their sequences, were obtained
from miRBase v.14 (21).
Gene expression pre-processing
Standard gene symbol and miRNA ID are used as our
primary identiﬁer. Genes and miRNAs with multiple
probes on the array, or those converted to the same
gene symbol/miRNA ID, are collapsed into a single
medium value. The normalized mRNA and miRNA ex-
pression data are pre-processed using three ﬁlters for low
(i) absolute expression, (ii) variance and (iii) entropy. A
cutoff of 5% is used for mRNA and miRNA expression
data individually to remove data that are not likely to be
important for the network. A list of the genes ﬁltered and
excluded from the analysis is available for user to down-
load. Finally, all matching conditions or samples between
the mRNA and miRNA data matrices are retained for
analysis. In case of multiple replicates for the same con-
dition, the median value between replicates is used.
Constructing the association network from gene
expression data
We construct an association network from the user-
supplied expression data by measuring the strength of all
pair-wise interactions between TFs, miRNAs and genes
across the samples/replicates. A number of parametric
and non-parametric association metrics is available to
the user for deﬁning these interactions. Correlation coef-
ﬁcient is one of the most intuitive, and most well received.
The different ﬂavors of correlation (Pearson, Spearman
and Kendall) have been used successfully in the past and
achieved different levels of success, for example in the
WGCNA R package (22). Pearson correlation coefﬁcient
is often used when a linear dependence between the vari-
ables exists. In contrast, Spearman r correlation coefﬁ-
cient applies Pearson formula on the ranks of the values
of the two variables and can detect similarities even if
non-linear (but monotonic) association exists. Kendall t
rank correlation coefﬁcient also operates on the ranks, but
it calculates the probability of concordance or discordance
of any pair of observations. In general, Spearman and
Kendall give similar results, but they differ on the magni-
tude [for more details on correlation measures, see Ref.
(23)]. We implemented these three correlation measures
and applied them on pairs of gene, TF or miRNA expres-
sion values across matching conditions. The absolute mag-
nitude reﬂects the level of correlation, and the sign
suggests positive or negative interaction. Mutual informa-
tion is a non-parametric test that has been implemented in
algorithms such as ARACNE (24) as the measure of an
association for genome-wide pairwise interactions. Mutual
information is non-negative, and as such it does not
provide information about the sign of interaction.
Furthermore, it is generally computationally intensive
and sample-size sensitive, since it requires an estimation
of marginal and joint probabilities of the variables. For all
these reasons, we are not currently implementing the
mutual information in miRconnX. The degree of associ-
ation, rassoc, is deﬁned as the probability that two genes
are correlated. We used the inverse of correlation coefﬁ-
cient signiﬁcance (1 p) as the probability of non-random
association. The use of signiﬁcance, instead of the coefﬁ-
cient itself, takes into account of the sample size and
allows a fair comparison between networks generated by
different sizes of data.
Network integration
Integration of the prior conﬁdence of association (based
on sequence data, literature evidence and predictions) and
the correlation network (based on the gene expression
data) is currently done via a simple weighted sum
function (S).
S ¼  priorðRgTF,RgmiRÞ+ assocðrassocÞ
In this equation,  prior is a user-deﬁned parameter
between 0 and 1, and  assoc=1  prior. The default for
 prior is 0.3 (i.e. 30%) and a value <0.5 is recommended
for the prior information. The user can also deﬁne a cutoff
for the combined regulation score, S. This is also a
number between 0.0 and 1.0. The higher the S the fewer
connections will be reported. A value of 0.7 0.99 is rec-
ommended. Finally, for practical purposes, we cap the
number of interactions to be displayed on screen at
3000, as beyond that the network becomes too large to
be efﬁciently visualized.
Submission and wait time
Depending on the size of the ﬁles (number of genes anal-
yzed) and types of analysis chosen, the analysis could take
anywhere from minutes to up to an hour. As an example,
for 20000 genes and 500 miRNA, the computing time is
roughly 15min using Pearson correlation. While the job is
running, an execution log will be displayed. The user can
close the browser window. When the job ﬁnishes, the user
will receive an email notiﬁcation and retrieve the results
from the link provided.
mirConnX output
Following the link to the result, a visualization of the
network is displayed, as shown in Figure 2. Cytoscape
Web v 0.7.2 (25) is used for network display. The render-
ing time for a network with 1500 nodes and 2500 connec-
tions is about 15s. Once uploaded, browsing the various
areas of the network is instantaneous. Users can use the
tools at the bottom right corner to zoom in/out and edit
node placements on the visualization page, and output the
visualization as graphics. The list of interactions is also dis-
played with links to external databases such as miRBase
and Entrez Gene (26) for annotation, PubFocus (27),
EBIMed (28), miR2Disease (29) and miRo (30) to facili-
tate clinical research by sifting through a large body of lit-
erature and records, as well as Gene Ontology (31) terms
Nucleic AcidsResearch, 2011, Vol.39, WebServer issue W419Figure 2. Snapshot of the glioblastoma case study output. An example search for the downstream targets of miR-21, a key player in glioblastoma
development, is shown in the middle.
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(i) list of interactions above the user-deﬁned display cutoff,
ranked by regulatory score in tab-delimited text ﬁle;
(ii) list of nodes, ranked by degree centrality in text-
delimited text ﬁle; and (iii) the network in pdf or
GRAPHML graph formats compatible with Cytoscape
for further exploration. The user can (iv) search for a par-
ticular node and its targets/regulators (through the ‘List of
gene interactions: ﬁltered’ drop down menu), a set of par-
ticular interaction and highlight or select the correspond-
ing nodes and edges on the graph display. Finally, we
display all (v) feed-forward loops and their neighbors at
the given threshold. In addition, a summary of statistics,
including the actual number of TFs, miRNAs and genes
can be retrieved under ‘execution log’.
CASE STUDY
The main idea behind mirConnX was ﬁrst used to analyze
lung epithelial gene expression data a few years ago (1,12).
In that study, we were able to identify a feed-forward loop
that included SMAD TFs, let-7d and HMGA2 gene,
which was central in the regulation of epithelial to mesen-
chymal transition (EMT). Furthermore, we later found
that knocking down of let-7d in the trachea of mice can
cause lung ﬁbrosis few days later (1).
Here, we present a case study that demonstrates the
utility of mirConnX. We downloaded a set of publicly
available mRNA and miRNA expression proﬁles from
The Cancer Genome Atlas (TCGA) pilot project (http://
cancergenome.nih.gov/), where a large compendium of
tumor and normal glioblastoma multiforme (GBM;
primary brain tumor) expression data is available. The
choice of this disease is two-fold: in this repository,
GBM is one of the two diseases with both tumor and
normal cells. Furthermore, recent studies have revealed
distinct patterns of miRNA expression in tumor
compared to normal brain (32) and several miRNA
targets have in fact been experimentally veriﬁed (33–35).
The disease samples are characterized by rapid prolifer-
ation and stem-cell like behavior that is possibly caused by
malfunctioning of characteristic pathways (36). Mutations
in miRNA and miRNA targets have been postulated to be
involved in tumorigenesis, but have not been speciﬁcally
identiﬁed in GBM.
The expression proﬁles downloaded consist of a total of
58 matched mRNA and miRNA samples from the Agilent
244k aCGH platform at data level 3. We used the follow-
ing parameters on mirConnX: Gene Symbols, miRBase
ID, Pearson correlation with a prior weight of 0.3 and
0.9 as the display cutoff threshold. A total of 56
miRNAs, 29 TFs and 1180 genes form a network with a
total of 1851 connections. Of these interactions, 43 are
miR-TF regulations, 34 TF-gene connections and 1774
miRNA–gene connections.
Among the top interactions, we were able to identify
four hubs: miR-21, miR-326, miR-34, and miR-137,
which have been veriﬁed to be miRNAs involved in
Gliobastoma. These four miRNAs are also hubs with
some of the highest degree centrality (37), sharing many
targets and TFs with other hubs. Among them, miR-21
has been found to be one of the most highly expressed
miRNAs in many cancer types, and it has been shown
that miR-21 acts as an oncogen in glioblastoma by sup-
pressing apoptosis (38). Among the highest ranking
targets we predict for miR-21, SOX2 (39) and TGFB
pathway (40) were shown to be regulated by the
miRNA. RECK and PDCD4 have been experimentally
veriﬁed, in vivo and in vitro, to be involved in proliferation
(34,41). In addition, PELI1 and CDC25A have been
shown in other cancer types to play a role in apoptosis
(38,42,43). Similarly, miR-137 has been shown to be
involved in proliferation and neuronal differentiation
in vitro (44). Indeed, both CDK6 and MITF, the experi-
mentally veriﬁed targets from the study were also pre-
dicted in our network.
A thorough literature search on all of the predicted
interactions for Gliobastoma is not possible here, but we
demonstrated that mirConnX is useful for identifying hub
genes, their regulators, and their targets involved in
diseases, the pathways involved and could potentially be
a powerful tool for clinical scientists to create a list of top
candidate genes and forming hypotheses.
CONCLUSIONS
In recent years, with the availability of condition-speciﬁc
high-throughput mRNA and miRNA expression data,
there is an increasing need of an integrated environment
that combines data analyses and visualization to construct
hypothesized networks. While many methods exist for
network generation using only expression data, only
binding afﬁnity experiments such as ChIP-chip, or even
manually curated data from expert knowledge databases,
an integrated network that maximally exploits informa-
tion in both domains is lacking. Additionally, there has
not been many attempts to incorporate both TF and
miRNA regulations, yet it has become increasingly clear
that miRNAs play a crucial role in human diseases.
mirConnX is a novel web tool developed speciﬁcally to
ﬁll the niche. The utility of mirConnX lies in its ability
to integrate user-supplied data with pre-compiled infor-
mation of miRNA targeting and TF binding, and
generate a network that reﬂects characteristics speciﬁc to
the data guided by some prior beliefs. The user-friendly
display of interaction networks and other downstream
analyses also provides an integrated environment for
clinical researchers to perform further investigation and
exploration.
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